Podcast episode

Back to fundamentals: The latest numbers point to better times

Bioworld Insider

Episode description

BioWorld Managing Editor Karen Carey joins the podcast to talk about the numbers from the first quarter of 2024, along with a look back at some 2023 deals and indicators that signal better times are on the way. Financings for the quarter were better than expected, sporting some of the best numbers of the past 13 years. It’s part of a larger trend, Carey says, of investors being a lot pickier about where they put their money and demanding better data. The result is a strengthened market and a better outlook.

Guest

Karen Carey
Karen Carey
BioWorld managing editor and analyst